ARCHIVES

Editorial: Rumor Mill Fills The Gap When Access Denied

This article is from The Cancer Letter archive.

Vol. 20 No. 48 | December 16, 1994

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000